;

Babraham Investor Conference 2019, WEDNESDAY 15TH MAY

Babraham Investor Conference (BIC) is a must attend one-day conference for investors focusing on early-stage and scale-up life science and med-tech companies from across the UK and Europe taking place on Wednesday 15th May 2019 at the Babraham Research Campus, Cambridge, UK.

Register Now


We are now calling for companies to apply to present at Start-up and Scale-up sessions. Applications close 5th April 2019.

Apply now

PITCHES FROM START-UP
& SCALE-UP COMPANIES

EARLY-STAGE SCIENCE
& MED-TECH COMPANIES

15 MINUTE PRESENTATION
SLOTS AVAILABLE

SPEAKERS FROM LIFE-SCIENCE
COMPANIES & INVESTORS

Apply to Present at the Babraham Investor Conference

Typically, presenting companies will be seeking funding of between £250K to £20M.  Presenting slots of 15 minutes each (including Q&A) are available.  There is also ample time for networking in-between sessions and the opportunity to have an exhibition stand. There is no charge to apply, however, we do request a fee of £100+VAT from each company successful in securing a slot to present.

To apply to present email us using the link below and you will receive a non-confidential investment profile to complete. All applications are reviewed by our panel and successful companies will be contacted via email.

Apply here

BIC 2019 Programme

Our programme is currently in development and will feature a rich programme of company presentations and networking opportunities. During the course of the day you can expect:

  • Expert-led panel discussions and company presentations.
  • Pitches from both start-up and scale up companies seeking investment.
  • Multiple opportunities to network with contacts and make new connections.
Programme

Speakers

Dr Anne Dobree

As Head of Seed Funds at Cambridge Enterprise, Anne has overseen strong growth in our investment activities, with Seed Funds investing over £5 million each year in young companies.

Dr Ian Tomlinson

Dr Ian Tomlinson is Chairman of the Board of the Stevenage Bioscience Catalyst, Chairman of the Investment Committee of Apollo Therapeutics and is a member of the Major Awards Committee for the UK governments BioMedical Catalyst funding scheme.

Sponsors

Handelsbanken

Handelsbanken is a full-service bank with a decentralised way of working, a strong local presence due to a nationwide network of over 200 branches and a long-term approach to customer relations.

Explore More

Taylor Vinters

Taylor Vinters is an international law firm supporting the businesses which drive the innovation economy, and the entrepreneurs and private wealth that underpin them.

Explore More

Contact us

BABRAHAM RESEARCH
CAMPUS

(+44) 1223 496 000
info@babraham.co.uk

Babraham Bioscience Technologies Ltd
Babraham Research Campus
Cambridge
CB22 3AT, United Kingdom

Press Enquiries

Limewash
01223 813 557
info@limewash.co.uk

Subscribe to our mailing list

Please enter your first name
Please enter your surname
Please enter your email address
Submit
; ;